Primary Record
etoposide
- In stock
- 1,875 g
- Purity
- 99.2 %
- CAS
- 33419-42-0
Compound Identifiers & Properties
- CAS
- 33419-42-0
- PubChem CID
- 36462
- SMILES
- C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
- Canonical SMILES
- COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O
Names & Synonyms
- etoposide
- VePesid
- Toposar
- trans-Etoposide
- Lastet
- (-)-Etoposide
- Zuyeyidal
- Etoposidum
- Etoposido
- Eposin
- 33419-42-0
- Vepesid J
- Etopophos
- Sintopozid
- Vepeside
- Eposide
- Etosid
- Etopol
- fytosid
- VP-16
- Vespid
- Etoposidum [INN-Latin]
- Etoposide (VP16)
- Etoposide Teva
- Etopophos;
- Etoposide*
- Abiposid;
- Vepeside;
- EPEG
- Amizide;
- Citodox;
- Toposar;
- Vepesid;
- Etoposide RS
- Teva, Etoposide
- Epipodophyllotoxin
- Etoposide CRS
- Exitop;
- Lastet S
- Etopophos (TN)
- Etoposido [INN-Spanish]
- VP 16 (pharmaceutical)
- Etopophos (phosphate salt)
- Eto GRY
- Eposin (TN)
- Etoposide (VP-16)
- AVOPEF
- Etoposide (Standard)
- VePESID (TN)
- Etoposide; VP-16
- Epipodophyllotoxin VP-16213
- 6PLQ3CP4P3
- ETOPOSIDE [INN]
- ETOPOSIDE [JAN]
- RefChem:56691
- UNII-6PLQ3CP4P3
- ETOPOSIDE [MI]
- VP 16
- ol-6(8H)-one
- ETOPOSIDE [HSDB]
- ETOPOSIDE [IARC]
- ETOPOSIDE [USAN]
- Prestwick3_000396
- CCRIS 2392
- ETOPOSIDE [VANDF]
- NSC-141540
- VP-16-213
- DTXSID5023035
- CHEMBL44657
- D09NIB
- D0B7EB
- ETOPOSIDE [MART.]
- Etoposide resolution mixture
- HSDB 6517
- AC1L1VT3
- ETOPOSIDE [USP-RS]
- ETOPOSIDE [WHO-DD]
- ETOPOSIDE [WHO-IP]
- SCHEMBL4259
- VP 16-213
- CHEBI:4911
- Etoposide [USAN:INN:BAN:JAN]
- NK 171
- BSPBio_000611
- MLS000049957
- MLS001074951
- MLS001424283
- MLS002153463
- MLS002207239
- MLS002222184
- NSC 141540
- VP 16213
- EINECS 251-509-1
- Etoposide - Bio-X trade mark
- [1,3]dioxol-6(5aH)-one
- C29H32O13
- Etoposide (JP15/USP/INN)
- Etoposide (JP18/USP/INN)
- MFCD00869325
- VJJPUSNTGOMMGY-MRVIYFEKSA-N
- BPBio1_000673
- DTXCID601473876
- GTPL6815
- orb1310906
- VP16
- ETOPOSIDE [EP IMPURITY]
- ETOPOSIDE [ORANGE BOOK]
- Etoposide, 98% - 1G 1g
- ETOPOSIDE [EP MONOGRAPH]
- ETOPOSIDE [USP IMPURITY]
- SCHEMBL29653657
- 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside
- ERK5-2O15
- ETOPOSIDE [USP MONOGRAPH]
- L01CB01
- Etoposide [USAN:BAN:INN:JAN]
- Etoposide, alpha D Glucopyranosyl
- ETOPOSIDUM [WHO-IP LATIN]
- NSC141540
- etoposide4-o-b-d-galactopyranoside
- HMS2052N05
- HMS2089F14
- HMS2096O13
- HMS2232L03
- HMS3713O13
- HMS6018O17
- PV-16
- VP-16 (TN)
- ETOPOSIDE (REFERENCE GRADE)
- Etoposide [USAN:USP:INN:BAN:JAN]
- CID36462
- DRG-0081
- EX-A1207
- ZINC3938684
- Tox21_110630
- Tox21_302201
- BDBM50127140
- EBC-11154
- Etoposide for system suitability CRS
- HY-13629R
- MSK001347
- NK-171
- NP4193
- NSC-14150
- s1225
- ZINC03978073
- CPD000112002
- Etoposide - CAS 33419-42-0
- AKOS007930275
- ACN-057122
- alpha-D-Glucopyranosyl Isomer Etoposide
- BCP9000669
- CCG-101165
- CS-1774
- CS-O-01452
- DB00773
- EBD2157958
- Etoposide, synthetic, >=98%, powder
- J3.178J
- LS-1214
- ME09941
- NC00415
- SDCCGSBI-0050405.P002
- C29-H32-O13
- NCGC00016821-01
- NCGC00179504-02
- NCGC00255126-01
- AS-35312
- BE164434
- Demethyl-epiodophyllotoxin ethylidene glucoside
- HY-13629
- SAM001246880
- SMR000112002
- VP-16213
- 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
- Demethyl Epipodophyllotoxin Ethylidine Glucoside
- Demethylepipodophyllotoxin-beta-D-ethylideneglucoside
- Pyridine, 2-chloro-5-(pentafluoroethyl)-
- SBI-0051910.P002
- CAS-33419-42-0
- VP 16 213
- VP 26-213
- VP-16-123
- 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
- AB00438905
- E0675
- FT-0630571
- FT-0777541
- NS00009585
- ST24047199
- Demethyl EpipodophyllotoxinEthylidine Glucoside
- EN300-97099
- Eposin, Vepesid, VP-16, Toposar, Etoposide
- A-8109
- C01576
- D00125
- 13165-EP2269989A1
- 13165-EP2270008A1
- 13165-EP2270014A1
- 13165-EP2270018A1
- 13165-EP2272827A1
- 13165-EP2272832A1
- 13165-EP2275413A1
- 13165-EP2275420A1
- 13165-EP2277565A2
- 13165-EP2277566A2
- 13165-EP2277567A1
- 13165-EP2277568A2
- 13165-EP2277569A2
- 13165-EP2277570A2
- 13165-EP2277865A1
- 13165-EP2277876A1
- 13165-EP2280012A2
- 13165-EP2281815A1
- 13165-EP2287156A1
- 13165-EP2289892A1
- 13165-EP2292280A1
- 13165-EP2292614A1
- 13165-EP2292615A1
- 13165-EP2292617A1
- 13165-EP2295055A2
- 13165-EP2295416A2
- 13165-EP2295426A1
- 13165-EP2295427A1
- 13165-EP2298305A1
- 13165-EP2298746A1
- 13165-EP2298748A2
- 13165-EP2298764A1
- 13165-EP2298765A1
- 13165-EP2298768A1
- 13165-EP2298772A1
- 13165-EP2298778A1
- 13165-EP2298780A1
- 13165-EP2301928A1
- 13165-EP2301933A1
- 13165-EP2305640A2
- 13165-EP2305642A2
- 13165-EP2305671A1
- 13165-EP2305679A1
- 13165-EP2305689A1
- 13165-EP2308812A2
- 13165-EP2308833A2
- 13165-EP2308839A1
- 13165-EP2308855A1
- 13165-EP2308861A1
- 13165-EP2311453A1
- 13165-EP2311807A1
- 13165-EP2311808A1
- 13165-EP2311825A1
- 13165-EP2311827A1
- 13165-EP2311829A1
- 13165-EP2311840A1
- 13165-EP2311842A2
- 13165-EP2314574A1
- 13165-EP2316832A1
- 13165-EP2316833A1
- 13165-EP2316834A1
- 13165-EP2374454A1
- AB00438905-17
- AB00438905-18
- AB00438905_19
- Epipodophyllotoxin-beta-D-ethyliden-glucoside, 4'-demethyl-
- 419E420
- A821765
- Q418817
- SR-01000763196
- 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside
- 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin
- Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
- Etoposide for system suitability CRS (Y0001365)
- SR-01000763196-3
- BRD-K37798499-001-02-5
- BRD-K37798499-001-05-8
- BRD-K37798499-001-10-8
- BRD-K37798499-001-14-0
- BRD-K37798499-001-18-1
- BRD-K37798499-001-21-5
- BRD-K37798499-001-22-3
- BRD-K37798499-001-25-6
- BRD-K37798499-001-27-2
- DEMETHY-EPIPODOPHYLLOTOXIN, ETHYLIDENE GLUCOSIDE
- -5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside
- 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside
- Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside
- Etoposide, British Pharmacopoeia (BP) Reference Standard
- Z1304065033
- Etoposide, European Pharmacopoeia (EP) Reference Standard
- (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
- (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside
- 9-((4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-
- 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,4-dimethyloxyphenyl)furo (3',4'':6,7) naptho-(2,3-d)-1,3-dioxol-6 (5aH)-one
- 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one
- Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside
- Etoposide, United States Pharmacopeia (USP) Reference Standard
- Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-(1R)-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-
- Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one-, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-
- 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside
- (10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2,7-trien-12-one
- (5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one
- (5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one
- 4 -Demethylepipodophyllotoxin 4,6-O-ethylidene-beta-D-glucopyranoside
- 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-b-D-glucopyranoside)
- 4'-demethylepipodophyllotoxin 9-[4,6-O-ethyl-idene-beta-D-glucopyranoside]
- 4?-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-b-D-glucopyranoside)
- EPE
- Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-
- Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-.beta.-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-
- 4''-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
- 4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-(R)-ETHYLIDENE-.BETA.-D-GLUCOPYRANOSIDE)
- Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI)
- Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside)
- Etoposide for system suitability, European Pharmacopoeia (EP) Reference Standard
- EtoposideETOPOSIDE</NOBR><br>CAS:33419-42-0<BR>MES-012
- (10R,11R,15R,16S)-16-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano(3,2-d)(1,3)dioxin-6-yl)oxy)-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo(7.7.0.0^(3,7).0^(11,15))hexadeca-1(9),2,7-trien-12-one
- (10R,11R,15R,16S)-16-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano(3,2-d)(1,3)dioxin-6-yl)oxy)-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo(7.7.0.03,7.011,15)hexadeca-1,3(7),8-trien-12-one
- (10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.03,7.011,15]hexadeca-1,3(7),8-trien-12-one
- (5R)-5,8,8abeta,9-Tetrahydro-9alpha-[4-O,6-O-[(R)-ethylidene]-beta-D-glucopyranosyloxy]-5beta-(4-hydroxy-3,5-dimethoxyphenyl)furo[3 ,4 :6,7]naphtho[2,3-d]-1,3-dioxol-6(5aalphaH)-one
- (5R)-9alpha-[[4-O,6-O-[(R)-Ethylidene]-beta-D-glucopyranosyl]oxy]-5,8,8abeta,9-tetrahydro-5beta-(4-hydroxy-3,5-dimethoxyphenyl)furo[3 ,4 :6,7]naphtho[2,3-d]-1,3-dioxol-6(5aalphaH)-one
- (5R,5aalpha)-9alpha-[4-O,6-O-[(R)-Ethylidene]-beta-D-glucopyranosyloxy]-5,8,8abeta,9-tetrahydro-5beta-(4-hydroxy-3,5-dimethoxyphenyl)furo[3 ,4 :6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
- (5R,5aalpha,9S)-9-[[4-O,6-O-[(R)-Ethylidene]-beta-D-glucopyranosyl]oxy]-5,8,8abeta,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3 ,4 :6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
- (5R,5AR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahy
- (5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]diox
- (5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d]
- (5R,5AR,8AR,9S)-9-((4,6-O-((1R)-ETHANE-1,1-DIYL)-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-5-(4-HYDROXY-3,5-DIMETHOXYPHENYL)-5,8,8A,9-TETRAHYDRO(2)BENZOFURO(5,6-F)(1,3)BENZODIOXOL-6(5AH)-ONE
- (5R,5aR,8aR,9S)-9-((4,6-O-(1R)-Ethylidene-beta-D-glucopyranosyl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro(3',4':6,7)naphtho(2,3-d)(1,3)dioxol-6(5aH)-one
- (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-|_-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
- (5R,5aR,8aR,9S)-9-[[4,6-O-(1R)-Ethylidene-beta-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one
- (5R,5aR,8aR,9S)-9-[4-O,6-O-[(R)-Ethylidene]-beta-D-glucopyranosyloxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3 ,4 :6,7]naphtho[2,3-d]-1,3-dioxole-6(5aH)-one
- (5S,5aR,8aR,9R)-5-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano(3,2-d)(1,3)dioxin-6-yl)oxy)-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-(2)benzofuro(6,5-f)(1,3)benzodioxol-8-one
- (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,3]benzodioxol-8-one
- (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one
- (5S,5aR,8aR,9R)-9-(4-Hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydro-2H-furo[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside
- (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3'',4'':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside
- (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol
- (5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol -5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside
- [5R-[5?,5a?,8a?,9?(R*)]]-9-[(4,6-?-Ethylidene-?-D-glucopyranosyl)oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6-(5aH)-one
- 118559-21-0
- 121471-01-0
- 251-509-1
- 9-((4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one
- 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3'',4'''':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one
- EPA
- Etoposide; Pyrano[3,2-d]-1,3-dioxin, furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one deriv.; (-)-Etoposide; Beposid; Bioposide; Celltop; EPE; Epipodophyllotoxin VP 16213; Eposed; Eposin; Ethopul; Eto-Gry; Etosid; Fytop; Fytosid; Lastet; NSC 141540; Nzytop; Sintopozid; Topok; Toposar; VP 16; VP 16 (pharmaceutical); VP 16-123; VP 16-213; VePesid; Vepesid J; Zuyeyidal; trans-Etoposide; (5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-beta-d-glucopyranosyl]oxy]-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one; Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-beta-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-; Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI); Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-beta
- EVP
- Furo [3', 4': 6,7] nafto [2,3-d]-1,3-dioxol-6 (5AH)-ona, 9-[[4,6-O-(1R)-etilideno-beta-D-glucopiranosil]oxi]-5,8,8 un,9-tetrahidro-5-(4-hidroxi-3,5-dimetoxifenil)-, (5R, 5aR, 8aR, 9S)-
- FURO(3',4':6,7)NAPHTHO(2,3-D)-1,3-DIOXOL-6(5AH)-ONE-, 9-((4,6-O-ETHYLIDENE-.BETA.-D-GLUCOPYRANOSYL)OXY)5,8,8A,9-TETRAHYDRO-5-(4-HYDROXY-3,5-DIMETHOXYPHENYL), (5R-(5.ALPHA.,5A.BETA.,8A.ALPHA.,9.BETA.(R*)))-
- Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[(4,6-O-ethylidene-.beta.-D-glucopyranosyl)oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, [5R-[5.alpha.,5a.beta.,8a.alpha.,9.beta.(R*)]]-